XML 60 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 21, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Trading Symbol CALC    
Entity Registrant Name CalciMedica, Inc.    
Entity Central Index Key 0001534133    
ICFR Auditor Attestation Flag false    
Document financial statement error correction false    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Common Stock, Shares Outstanding   10,740,115  
Entity Public Float     $ 11.7
Entity File Number 001-39538    
Entity Tax Identification Number 45-2120079    
Entity Address, Address Line One 505 Coast Boulevard South    
Entity Address, Address Line Two Suite 307    
Entity Address, City or Town La Jolla    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92037    
City Area Code 858    
Local Phone Number 952-5500    
Entity Interactive Data Current Yes    
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Security Exchange Name NASDAQ    
Entity Incorporation, State or Country Code DE    
Document Annual Report true    
Document Transition Report false    
Auditor Name Ernst & Young LLP    
Auditor Firm ID 42    
Auditor Location San Diego, California    
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive Proxy Statement (the “Proxy Statement”) for the 2024 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission not later than April 29, 2024 are incorporated by reference into Part III of this Annual Report on Form 10-K